http://www.unboundmedicine.com/medline/ebm/research/TaxotereUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19050703/full_citation/Dexamethasone_potentiates_the_antiangiogenic_activity_of_docetaxel_in_castration_resistant_prostate_cancer_Wilson C, Scullin P, Worthington J, et al. 
Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer. [JOURNAL ARTICLE]
Br J Cancer 2008 Dec 2.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19047143/full_citation/Ionizing_Radiation_Induces_Prostate_Cancer_Neuroendocrine_Differentiation_through_Interplay_of_CREB_and_ATF2:_Implications_for_Disease_Progression_Deng X, Liu H, Huang J, et al. 
Ionizing Radiation Induces Prostate Cancer Neuroendocrine Differentiation through Interplay of CREB and ATF2: Implications for Disease Progression. [Journal Article]
Cancer Res 2008 Dec 1; 68(23):9663-70.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19047121/full_citation/Phase_I/II_Study_of_G3139__Bcl_2_Antisense_Oligonucleotide__in_Combination_with_Doxorubicin_and_Docetaxel_in_Breast_Cancer_Moulder SL, Symmans WF, Booser DJ, et al. 
Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer. [JOURNAL ARTICLE]
Clin Cancer Res 2008 Dec 1; 14(23):7909-7916.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19046802/full_citation/Low_dose_combinations_of_2_methoxyestradiol_and_docetaxel_block_prostate_cancer_cells_in_mitosis_and_increase_apoptosis_Reiner T, Pozas AD, Gomez LA, et al. 
Low dose combinations of 2-methoxyestradiol and docetaxel block prostate cancer cells in mitosis and increase apoptosis. [JOURNAL ARTICLE]
Cancer Lett 2008 Nov 27.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19038730/full_citation/Chemotherapy_for_advanced_stage_non_small_cell_lung_cancer_Fathi AT, Brahmer JR 
Chemotherapy for advanced stage non-small cell lung cancer. [Journal Article]
Semin Thorac Cardiovasc Surg 2008; 20(3):210-6.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19036903/full_citation/Economic_analysis_of_albumin_bound_paclitaxel_for_the_treatment_of_metastatic_breast_cancer_Dranitsaris G, Cottrell W, Spirovski B, et al. 
Economic analysis of albumin-bound paclitaxel for the treatment of metastatic breast cancer. [JOURNAL ARTICLE]
J Oncol Pharm Pract 2008 Nov 26.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19034450/full_citation/Simplified_FOLFIRI_in_pre_treated_patients_with_metastatic_gastric_cancer_Lorizzo K, Fazio N, Radice D, et al. 
Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2008 Nov 26.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19034449/full_citation/Stable_XIAP_knockdown_clones_of_HCT116_colon_cancer_cells_are_more_sensitive_to_TRAIL_taxanes_and_irradiation_in_vitro_Connolly K, Mitter R, Muir M, et al. 
Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2008 Nov 26.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19034280/full_citation/Antiproliferative_activity_of_PEP005_a_novel_ingenol_angelate_that_modulates_PKC_functions_alone_and_in_combination_with_cytotoxic_agents_in_human_colon_cancer_cells_Benhadji KA, Serova M, Ghoul A, et al. 
Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells. [JOURNAL ARTICLE]
Br J Cancer 2008 Dec 2; 99(11):1808-1815.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19027483/full_citation/Gefitinib_versus_docetaxel_in_previously_treated_non_small_cell_lung_cancer__INTEREST_:_a_randomised_phase_III_trial_Kim ES, Hirsh V, Mok T, et al. 
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial. [Journal Article, Research Support, Non-U.S. Gov't]
Lancet 2008 Nov 22; 372(9652):1809-18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles